3189 results for «704»

Filter By

3189 results

Imaging for structural heart disease intervention

19 Feb 2023 – From PCR Tokyo Valves 2023

Consult this session if you want to learn about imaging in structural heart interventions by exploring series of slides on restoration post transcatheter mitral valve repair, diagnostic performance of CT angiography, and AI in aortic complex measurement for TAVI, and more! 

Other cardiac interventions

19 Feb 2023 – From PCR Tokyo Valves 2023

Explore innovative approaches to cardiac interventions featured at PCR Tokyo Valves 2023: from performing TricValve implantation in Asian patients to addressing unique cases like transcatheter valve replacement with a novel tricuspid bioprosthesis. Discover how these experts navigated challenging scenarios!

TAVI in patients with heavily calcified aortic root

19 Feb 2023 – From PCR Tokyo Valves 2023

What role does TAVI play in patients' severely calcified roots? Study the use of balloon-expandable devices, assessing the impact of calcification on aortic root rupture, strategies for safe and effective procedures, and when to consider surgical AVR.

Mitral valve implantation and other technology

19 Feb 2023 – From PCR Tokyo Valves 2023

This session offers insight into advanced mitral valve technologies. It covers details of transapical off-pump repair with synthetic chordae, India's success in transcatheter double valve-in-valve,  TMVI in failing valves, and more.

Coronary access after TAVI

19 Feb 2023 – From PCR Tokyo Valves 2023

Unlock insights into post-TAVI coronary access. Understand transcatheter aortic valve structure, neo-commissure anatomy, and practical techniques. This session covers topics such as optimising commissure alignment, elective CAG/PCI, ACS, and severe aortic stenosis.

COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 (AstraZeneca/Oxford)

02 Jan 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: safety and efficacy of the ChAdOx1 nCoV-19 vaccine

20 years of TAVI - Revolutionising medicine since 2002

18 May 2022

Twenty years ago, surgical aortic valve replacement (SAVR) was the only real option for patients with symptomatic aortic stenosis, and if the patient was considered at high operative risk, alternatives were very limited.

Prof. Alain Cribier

Author

Alain Cribier

Author

Helene Eltchaninoff
Rudiger Lange

Author

Rudiger Lange
Stan Rabinovich

Author

Stan Rabinovich
Happy birthday TAVI – 20 years old this year

The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

01 Sep 2022

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Alessandro Sticchi

Author

Alessandro Sticchi
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

COVID-19 vaccines: Burning questions from the community and real-world applicability

13 Jan 2021

View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.

COVID-19 vaccines: Burning questions from the community and real-world applicability
Didn’t find what you were looking for?